Acta Psychiatr Scand
- HUANG MH, Cheng CM, Hsu JW, Bai YM, et al
Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major
Depressive Disorder: A Cohort Study of 183,504 Subjects.
Acta Psychiatr Scand. 2025 Oct 30. doi: 10.1111/acps.70043.
Am J Psychiatry
- KALIN NH
Schizophrenia, Alcohol Use Disorder, and Stimulant Use Disorder.
Am J Psychiatry. 2025;182:957-959.
- YALCINBAS EA, Ajanaku B, Nelson ED, Garcia-Flores R, et al
Transcriptomic Analysis of the Human Habenula in Schizophrenia.
Am J Psychiatry. 2025;182:991-1006.
- GUR RE
Pathways to Psychosis: Factors Associated With Risk for Psychosis Spectrum
Disorders.
Am J Psychiatry. 2025;182:984-990.
- ZHAO G, Sun Y, Zhang Y, Lu T, et al
Efficacy and Tolerability of Seven Antipsychotic Drugs in Acutely Ill Patients
With Schizophrenia: A Randomized, Multicenter, Assessor-Blinded Trial.
Am J Psychiatry. 2025 Oct 29:appiajp20250111. doi: 10.1176/appi.ajp.20250111.
Biol Psychiatry
- WANG HR, Liu ZQ, Nomi JS, Schleifer CH, et al
Multivariate Resting-State Functional Connectivity Features Linked to
Transdiagnostic Psychopathology in Early Psychosis.
Biol Psychiatry. 2025 Oct 29:S0006-3223(25)01573.
- BERGINK V, Akbarian S, Byatt N, Chandra PS, et al
Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert
Consensus Statement on classification.
Biol Psychiatry. 2025 Oct 22:S0006-3223(25)01536.
BMJ
- STOKEL-WALKER C
AI driven psychosis and suicide are on the rise, but what happens if we turn the
chatbots off?
BMJ. 2025;391:r2239.
Br J Psychiatry
- LIU W, Wang C, Guo F, Guo M, et al
Structural connectivity of striatal subregions in first-episode schizophrenia:
links to positive symptoms and treatment response.
Br J Psychiatry. 2025 Oct 24:1-8. doi: 10.1192/bjp.2025.10434.
J Clin Psychopharmacol
- SPIEGEL DR, Wallace T, Kozlova V, Hoff M, et al
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With
Schizophrenia.
J Clin Psychopharmacol. 2025 Oct 29. doi: 10.1097/JCP.0000000000002101.
- DE LAS CUEVAS C, Sanz EJ, de Leon J
Fatal Outcomes in Use of Clozapine: A VigiBase Study of 6402 Women and 11,222
Men.
J Clin Psychopharmacol. 2025;45:547-553.
J Psychiatry Neurosci
- KORCHIA T, Palaniyappan L
Sexual reactivation under aripiprazole in schizophrenia: a note for prescribers.
J Psychiatry Neurosci. 2025;50:E334-E336.
- MARQUES D, Spindola L, Narang A, Vaziri N, et al
Differential DNA methylation and gene expression in stem cell-derived
cardiomyocytes from patients with and without a history of clozapine-induced
myocarditis.
J Psychiatry Neurosci. 2025;50:E323-E333.
Mol Psychiatry
- BATALLA A, Somers M, Meer PV
Psychedelics, psychosis, and the elusive notion of safety.
Mol Psychiatry. 2025 Oct 24. doi: 10.1038/s41380-025-03315.
PLoS One
- MARTI-GARCIA C, Quemada-Gonzalez C, Aguilera-Serrano C, Mejias Martin Y, et al
Changing the narrative: A qualitative study on the impact of media portrayals on
people with schizophrenia.
PLoS One. 2025;20:e0335008.
Psychiatry Res
- GUO X, Wu S, Jia T, Sun Z, et al
Plasma fatty acids levels and risk of schizophrenia in the UK Biobank: a
prospective cohort study.
Psychiatry Res. 2025;354:116805.
- DELISI LE
Reflections from half a century of progress searching for the causes of
schizophrenia: Stanley Dean award presentation 2025.
Psychiatry Res. 2025;354:116790.
- VERDAGUER-RODRIGUEZ M, Lopez-Carrilero R, Diaz-Cutraro L, Ferrer-Quintero M, et al
Sex-based differences in neurocognitive functioning in first-episode psychosis:
An exploratory analysis.
Psychiatry Res. 2025;354:116803.
- HU G, Wei D, Zhang J, Liu J, et al
Effect of computerized cognitive remediation therapy combined with individualized
occupational therapy on cognitive function and functional outcomes in patients
with schizophrenia: A randomized controlled trial.
Psychiatry Res. 2025;354:116789.
- ZENCIR T, Celik Zencir A, Tekinarslan G, Koc M, et al
The role of socioeconomic and structural vulnerability risk factors in employment
outcomes for individuals with Schizophrenia and other psychotic disorders.
Psychiatry Res. 2025;354:116782.
Psychol Med
- HYAT M, Zhu J, Boltz TA, Conomos MP, et al
Independent versus joint effects of polygenic or family-based schizophrenia risk
in diverse ancestry youth in the ABCD study.
Psychol Med. 2025;55:e327.
- DJORDJEVIC M, Gangadin SS, de Haan L, Jongsma HE, et al
Psychological side effects of antipsychotic medication after remission from
first-episode psychosis: a HAMLETT ecological momentary assessment study.
Psychol Med. 2025;55:e325.
- RABALLO A, Poletti M, Preti A
Connecting the empirical dots on antipsychotic exposure and treatment in clinical
high-risk for psychosis.
Psychol Med. 2025;55:e320.
- LI Y, Yu M, Yang H, Shi L, et al
Efficacy of adjunctive antidepressants in treating negative symptoms of
schizophrenia: a systematic review and network meta-analysis.
Psychol Med. 2025;55:e317.
Schizophr Res
- IMAMOGLU A, Penn DL, Harvey PD, Pinkham AE, et al
Impaired recognition of neutral faces in schizophrenia is linked to hostile
attribution bias and paranoia.
Schizophr Res. 2025;286:97-99.
- WANG K, Sun Y, Xia C, Yang X, et al
Subfield-specific hippocampal microstructural alterations in schizophrenia: A
high-resolution DTI study.
Schizophr Res. 2025;286:89-96.
- MYERS EJ, Lysaker PH, Rand KL, Salyers MP, et al
Disorganization and disintegration in schizophrenia: Metacognitive capacity
across levels of conceptual disorganization.
Schizophr Res. 2025;286:82-88.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016